Drug Development

Nevena Vicic, MSc, MBiotech, discusses how to take control of your career

Driving down costs and clarifying the value of trial components is imperative to get drugs to market

New guidance to help companies prepare to quickly and effectively remove violative products from the market

Models allow for virtual trials of drugs and vaccines, to test their efficacy against COVID-19

The blueprint will enable the development of tailor-made drugs to treat epilepsy or cardiovascular diseases

Research results could one day lead to advanced screening methods to discern who is at greatest risk of developing disease

Robust workflow solution enables rapid, high throughput protein affinity purifications

Live dashboard offers an overview of all the trials taking place in the international effort to tackle the pandemic

KIT scientists develop process that facilitates and accelerates chemical synthesis and biological screening by combining all steps on a chip

The journey from lead discovery to final approval can be long and challenging